Internal Medicine, Hematology & Oncology · Staten Island, NY
NPI
1851300271
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2801 Richmond Ave
Staten Island, NY, 10301
Phone (332) 963-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
115,108 services
Medicare patients, 2024
440
Average age 74
Drug cost, 2024
$5.4M
1,421 prescriptions
Company payments, 2025
$1,461
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Seetha R Murukutla was code J1756 (injection, iron sucrose, 1 mg), 22,800 times for 32 patients. In total Seetha R Murukutla billed 115,108 services in 176 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 22,800 | 32 | $0.17 | $3,963 |
| J0897 Injection, denosumab, 1 mg | Office | 5,400 | 45 | $20.53 | $111K |
| 36415 Venipuncture Blood Collection | Office | 1,817 | 402 | $8.65 | $16K |
| 85025 Blood Count | Office | 1,727 | 398 | $7.61 | $13K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,680 | 22 | $0.09 | $148 |
| 80053 Clinical Chemistry | Office | 1,277 | 389 | $10.35 | $13K |
| 82728 Clinical Chemistry | Office | 1,064 | 384 | $13.34 | $14K |
| 99214 Office E&M - Established | Office | 901 | 328 | $106.46 | $96K |
| 83540 Clinical Chemistry | Office | 841 | 361 | $6.32 | $5,313 |
| 83550 Clinical Chemistry | Office | 828 | 357 | $8.54 | $7,071 |
| 82784 Immunoassay | Office | 807 | 143 | $9.11 | $7,354 |
| 84443 Clinical Chemistry | Office | 742 | 361 | $16.46 | $12K |
| 84439 Clinical Chemistry | Office | 736 | 361 | $8.83 | $6,498 |
| 82607 Clinical Chemistry | Office | 702 | 365 | $14.76 | $10K |
| 88185 Surgical Pathology Examination | Office | 414 | 16 | $22.32 | $9,241 |
By year: 2022 $2.7M for 202,975 services; 2023 $2.0M for 138,819 services; 2024 $1.6M for 115,108 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,817 | 402 | $8.65 | $16K |
| 85025 Blood Count | 1,727 | 398 | $7.61 | $13K |
| 80053 Clinical Chemistry | 1,277 | 389 | $10.35 | $13K |
| 82728 Clinical Chemistry | 1,064 | 384 | $13.34 | $14K |
| 83540 Clinical Chemistry | 841 | 361 | $6.32 | $5,313 |
| 83550 Clinical Chemistry | 828 | 357 | $8.54 | $7,071 |
| 82784 Immunoassay | 807 | 143 | $9.11 | $7,354 |
| 84443 Clinical Chemistry | 742 | 361 | $16.46 | $12K |
| 84439 Clinical Chemistry | 736 | 361 | $8.83 | $6,498 |
| 82607 Clinical Chemistry | 702 | 365 | $14.76 | $10K |
Medicare prescription drug claims, 2024
In 2024, the drug Seetha R Murukutla prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 129 prescriptions and refills. In total Seetha R Murukutla wrote 1,421 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 129 | 129 | 29 | $139K |
| Aranesp Darbepoetin Alfa In Polysorbat | 87 | 89 | 24 | $309K |
| Akynzeo Fosnetupitant/Palonosetron | 74 | 74 | 19 | $122K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 57 | 57 | Under 11 | $706K |
| Eliquis Apixaban | 36 | 48 | Under 11 | $28K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 32 | 32 | Under 11 | $143K |
| Xgeva Denosumab | 27 | 37 | Under 11 | $86K |
| Duloxetine Hcl Generic | 26 | 44 | Under 11 | $621 |
| Prednisone Generic | 26 | 37 | Under 11 | $138 |
| Neulasta Pegfilgrastim | 25 | 25 | Under 11 | $212K |
| Acyclovir Generic | 25 | 69 | 11 | $295 |
| Kyprolis Carfilzomib | 24 | 24 | Under 11 | $206K |
| Nubeqa Darolutamide | 23 | 23 | Under 11 | $297K |
| Brukinsa Zanubrutinib | 23 | 23 | Under 11 | $324K |
| Ondansetron Odt Ondansetron | 23 | 23 | 12 | $549 |
Brand drugs: 864 claims; generic drugs: 557 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Seetha R Murukutla $1,461 ($1,461 in general payments such as food, travel and fees) from 11 companies. The largest payer was Adaptive Biotechnologies Corporation with $602.
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation ADPT | 7 | $602 |
| Abbvie Inc. ABBV | 2 | $199 |
| Daiichi Sankyo Inc. 4568.T | 3 | $164 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $138 |
| Geron Corporation GERN | 1 | $120 |
| Array Biopharma Inc PFE | 3 | $63.27 |
| Merck Sharp & Dohme LLC MRK | 3 | $58.86 |
| Seagen Inc. PFE | 1 | $38.99 |
| Janssen Biotech, Inc. JNJ | 2 | $34.87 |
| Recordati_rare_diseases_inc. | 1 | $23.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.